更新于：2024-11-04
Cephalothin Sodium
头孢噻吩钠
更新于：2024-11-04
概要
基本信息
原研机构 |
非在研机构 |
最高研发阶段批准上市 |
首次获批日期 美国 (1974-12-18), |
最高研发阶段(中国)批准上市 |
特殊审评- |
登录后查看时间轴
结构
分子式C16H16N2NaO6S2 |
InChIKeyXXDPRVHYESWPEX-XRZFDKQNSA-N |
CAS号58-71-9 |
关联
2
项与 头孢噻吩钠 相关的临床试验A Randomized Clinical Trial on the Efficacy and Cost-efficacy of Adding on a Mindfulness-based Therapy to Standard Medical Prophylaxis in the Treatment of Patients With Chronic Migraine Associated to Medication Overuse Following Structured Withdrawal: the Mind-CM Study
Use of Mosquito Net Mesh in Comparison With Polypropylene Mesh for Ventral Hernia Repair.
100 项与 头孢噻吩钠 相关的临床结果
登录后查看更多信息
100 项与 头孢噻吩钠 相关的转化医学
登录后查看更多信息
100 项与 头孢噻吩钠 相关的专利（医药）
登录后查看更多信息
4,048
项与 头孢噻吩钠 相关的文献（医药）2024-12-31Future Science OA
Formulation and characterization of antibiotic drug loaded aquasome for the topical application
Article
作者: Shanmugam, Bhuvaneshwari ; Srinivasan, Umashankar Marakanam
Aim: This study aimed to develop a topical antibiotic drug delivery system using aquasomes for enhanced treatment of skin and soft tissue infections (SSTIs). Materials & methods: Cephalothin was loaded into aquasomes using a multi-step process and optimized using design of experiment. The aquasomes were characterized for FT-IR, SEM and zeta potential analysis. Entrapment efficacy, In vitro drug release studies, antibacterial assays and stability study was performed to evaluate the efficacy of the formulated aquasomes. Results & conclusion: The formulated cephalothin-loaded aquasomes exhibited stable properties, controlled drug release and significant antibacterial activity against bacteria. This proves that the developed aquasome-based delivery system has the potential for sustained treatment of SSTIs.
2024-10-22ACS Omega
Little-Cost Potentiometric and Spectrophotometric Procedures for Cephalothin Assessment in Pure and Biological Fluids
Article
作者: A. Farghaly, Othman
Low-cost potentiometric and spectrophotometric procedures for cephalothin (CPI) determination in pure and biological fluids were investigated. The potentiometric technique is created through titration of CPI with an aqueous medium of 0.1 M NaOH at an ionic strength of μ = 0.3 M sodium chloride and room temperature by a combined glass pH electrode. Using the standard addition method, we found that the detection and quantitative limits were 0.042 mg/mL, with the standard deviation SD = 0.011, correlation coefficient R = 0.9880 (n = 5), and linear concentration ranges from 0.042 to 0.82 mg/mL. This technique was utilized to assess CPI in pure solutions, urine, and serum with suitable results. No interference was exposed in the presence of public components of the samples under study. Recovery of CPI for pure and biological fluids is in the range of 98.2-101%. Also, the spectrophotometric method has been performed through the formation of the Prussian Blue (PB) complex. The reaction between the acidic hydrolysis product of CPI (T = 60 °C) and the mixture of Fe3+ with hexacyanoferrate (III) ions (HCF(III)) was detected for the spectrophotometric determination of the drug. The maximum absorbance of the formed complex was measured at λ = 283 nm with 2.0 × 103 L mol-1 cm-1 molar absorptivity. Reaction states have been advanced to acquire the PB complex of great sensitivity and longer stability. In optimal states, the absorbent of the PB compound was attained to grow linearly with the increase in the concentration of CPI, which agrees with the correlation coefficient values. The detection and quantitative limits were 0.000036 and 0.0012 mg/mL, respectively, with the standard deviation, SD = 0.0005, correlation coefficient, R = 0.9955 (n = 5), and the linearity range of the calibration plot 0.0005-0.02 mg/mL CPI. The planned technique was positively utilized for the detection of CPI in both urine and serum models. The results fit well with the data found from the potentiometric method.
2024-10-10Microbiology Resource Announcements
Complete genome sequence of cephalosporin and tetracycline-resistant
Citrobacter freundii
CF51 isolate from a patient with urinary tract infection
Article
作者: Revollo, Javier ; Nawaz, Mohamed ; Khan, Saeed A. ; Miranda, Jaime A. ; Sung, Kidon ; Park, Miseon ; Feye, Kristina
ABSTRACT:
We report here the complete genome sequence of cephalosporin (cefazolin and cephalotin) and tetracycline-resistant
Citrobacter freundii
strain CF51, isolated from a patient with a urinary tract infection. The genome comprises a 5.0-Mb chromosome, along with an 87.2-kb plasmid and a 23.9-kb plasmid.
100 项与 头孢噻吩钠 相关的药物交易
登录后查看更多信息
研发状态
10 条最早获批的记录, 后查看更多信息
登录
| 适应症 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|
| 菌血症 | 日本 | 1976-09-01 | |
| 复杂皮肤和皮肤结构感染 | 日本 | 1976-09-01 | |
| 肺脓肿 | 日本 | 1976-09-01 | |
| 骨髓炎 | 日本 | 1976-09-01 | |
| 中耳炎 | 日本 | 1976-09-01 | |
| 腹膜炎 | 日本 | 1976-09-01 | |
| 猩红热 | 日本 | 1976-09-01 | |
| 扁桃体炎 | 日本 | 1976-09-01 | |
| 细菌感染 | 美国 | 1974-12-18 |
登录后查看更多信息
临床结果
临床结果
适应症
分期
评价
查看全部结果
N/A | 19 | 簾顧醖襯簾襯餘鏇鬱壓(鹽遞蓋願壓繭膚壓製廠) = 夢鹽艱餘繭衊糧鹽廠壓 壓構壓襯築製壓憲襯願 (願顧糧醖鹽夢廠齋襯衊 ) 更多 | 积极 | 2014-11-11 | |||
簾顧醖襯簾襯餘鏇鬱壓(鹽遞蓋願壓繭膚壓製廠) = 網願衊鑰蓋鬱繭齋積襯 壓構壓襯築製壓憲襯願 (願顧糧醖鹽夢廠齋襯衊 ) 更多 |
登录后查看更多信息
转化医学
使用我们的转化医学数据加速您的研究。
登录
或
药物交易
使用我们的药物交易数据加速您的研究。
登录
或
核心专利
使用我们的核心专利数据促进您的研究。
登录
或
临床分析
紧跟全球注册中心的最新临床试验。
登录
或
批准
利用最新的监管批准信息加速您的研究。
登录
或
特殊审评
只需点击几下即可了解关键药物信息。
登录
或
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。
生物序列数据库
生物药研发创新
免费使用
化学结构数据库
小分子化药研发创新
免费使用